Cargando…

HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?

Background: The high-temperature requirement A 1 (HtrA1) is a multidomain secretory protein with serine-protease activity, expressed in many tissues, including placenta, where its expression is higher in the first trimester, suggesting an association of this serine protease in early phases of human...

Descripción completa

Detalles Bibliográficos
Autores principales: Tossetta, Giovanni, Fantone, Sonia, Gesuita, Rosaria, Di Renzo, Gian Carlo, Meyyazhagan, Arun, Tersigni, Chiara, Scambia, Giovanni, Di Simone, Nicoletta, Marzioni, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689498/
https://www.ncbi.nlm.nih.gov/pubmed/36359548
http://dx.doi.org/10.3390/diagnostics12112705
_version_ 1784836550220054528
author Tossetta, Giovanni
Fantone, Sonia
Gesuita, Rosaria
Di Renzo, Gian Carlo
Meyyazhagan, Arun
Tersigni, Chiara
Scambia, Giovanni
Di Simone, Nicoletta
Marzioni, Daniela
author_facet Tossetta, Giovanni
Fantone, Sonia
Gesuita, Rosaria
Di Renzo, Gian Carlo
Meyyazhagan, Arun
Tersigni, Chiara
Scambia, Giovanni
Di Simone, Nicoletta
Marzioni, Daniela
author_sort Tossetta, Giovanni
collection PubMed
description Background: The high-temperature requirement A 1 (HtrA1) is a multidomain secretory protein with serine-protease activity, expressed in many tissues, including placenta, where its expression is higher in the first trimester, suggesting an association of this serine protease in early phases of human placenta development. In this study, we evaluated maternal serum HtrA1 levels in the first and third trimester of gestation. In particular, we evaluated a possible role of HtrA1 as an early marker of gestational diabetes mellitus (GDM) in the first trimester of gestation. Methods: We evaluated HtrA1 serum levels in the third trimester (36–40 weeks) in normal pregnancies (n = 20) and GDM pregnancies (n = 20) by using ELISA analysis. Secondly, we performed the same analysis by using the first trimester sera (10–12 weeks) of healthy pregnant women that will develop a normal pregnancy (n = 210) or GDM (n = 28) during pregnancy. Results: We found that HtrA1 serum levels in the third trimester were higher in pregnancies complicated by GDM. Interestingly, higher HtrA1 serum levels were also found in the first trimester in women developing GDM later during the second–third trimester. No significant differences in terms of maternal age and gestational age were found between cases and controls. Women with GDM shown significantly higher pre-pregnancy BMI values compared to controls. Moreover, the probability of GDM occurrence significantly increased with increasing HtrA1 levels and BMI values. The ROC curve showed a good accuracy in predicting GDM, with an AUC of 0.74 (95%CI: 0.64–0.92). Conclusions: These results suggest an important role of HtrA1 as an early predictive marker of GDM in the first trimester of gestation, showing a significative clinical relevance for prevention of this disease.
format Online
Article
Text
id pubmed-9689498
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96894982022-11-25 HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker? Tossetta, Giovanni Fantone, Sonia Gesuita, Rosaria Di Renzo, Gian Carlo Meyyazhagan, Arun Tersigni, Chiara Scambia, Giovanni Di Simone, Nicoletta Marzioni, Daniela Diagnostics (Basel) Article Background: The high-temperature requirement A 1 (HtrA1) is a multidomain secretory protein with serine-protease activity, expressed in many tissues, including placenta, where its expression is higher in the first trimester, suggesting an association of this serine protease in early phases of human placenta development. In this study, we evaluated maternal serum HtrA1 levels in the first and third trimester of gestation. In particular, we evaluated a possible role of HtrA1 as an early marker of gestational diabetes mellitus (GDM) in the first trimester of gestation. Methods: We evaluated HtrA1 serum levels in the third trimester (36–40 weeks) in normal pregnancies (n = 20) and GDM pregnancies (n = 20) by using ELISA analysis. Secondly, we performed the same analysis by using the first trimester sera (10–12 weeks) of healthy pregnant women that will develop a normal pregnancy (n = 210) or GDM (n = 28) during pregnancy. Results: We found that HtrA1 serum levels in the third trimester were higher in pregnancies complicated by GDM. Interestingly, higher HtrA1 serum levels were also found in the first trimester in women developing GDM later during the second–third trimester. No significant differences in terms of maternal age and gestational age were found between cases and controls. Women with GDM shown significantly higher pre-pregnancy BMI values compared to controls. Moreover, the probability of GDM occurrence significantly increased with increasing HtrA1 levels and BMI values. The ROC curve showed a good accuracy in predicting GDM, with an AUC of 0.74 (95%CI: 0.64–0.92). Conclusions: These results suggest an important role of HtrA1 as an early predictive marker of GDM in the first trimester of gestation, showing a significative clinical relevance for prevention of this disease. MDPI 2022-11-05 /pmc/articles/PMC9689498/ /pubmed/36359548 http://dx.doi.org/10.3390/diagnostics12112705 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tossetta, Giovanni
Fantone, Sonia
Gesuita, Rosaria
Di Renzo, Gian Carlo
Meyyazhagan, Arun
Tersigni, Chiara
Scambia, Giovanni
Di Simone, Nicoletta
Marzioni, Daniela
HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?
title HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?
title_full HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?
title_fullStr HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?
title_full_unstemmed HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?
title_short HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?
title_sort htra1 in gestational diabetes mellitus: a possible biomarker?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689498/
https://www.ncbi.nlm.nih.gov/pubmed/36359548
http://dx.doi.org/10.3390/diagnostics12112705
work_keys_str_mv AT tossettagiovanni htra1ingestationaldiabetesmellitusapossiblebiomarker
AT fantonesonia htra1ingestationaldiabetesmellitusapossiblebiomarker
AT gesuitarosaria htra1ingestationaldiabetesmellitusapossiblebiomarker
AT direnzogiancarlo htra1ingestationaldiabetesmellitusapossiblebiomarker
AT meyyazhaganarun htra1ingestationaldiabetesmellitusapossiblebiomarker
AT tersignichiara htra1ingestationaldiabetesmellitusapossiblebiomarker
AT scambiagiovanni htra1ingestationaldiabetesmellitusapossiblebiomarker
AT disimonenicoletta htra1ingestationaldiabetesmellitusapossiblebiomarker
AT marzionidaniela htra1ingestationaldiabetesmellitusapossiblebiomarker